Does application of topical steroids for lichen sclerosus (balanitis xerotica obliterans) affect the rate of circumcision? A systematic review
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Feb 2018 · 1 min read
In brief
In brief
Systematic review of 89 pediatric patients shows topical corticosteroid treatment for lichen sclerosus avoided circumcision in 35% of cases. However, treatment duration and follow-up periods were short across analyzed studies, indicating need for prospective randomized trials to establish definitive efficacy.
Written by the GCMD Library team from the article.
Purpose
To determine whether treatment of lichen sclerosus et atrophicus (LS), with topical steroids reduces the rate of circumcision.
Methods
Two independent reviewers performed a literature search of studies reporting treatment of LS with topical steroids using EMBASE and MEDLINE database(s). Inclusion criteria: boys aged 0–18 years, clinical diagnosis of LS, treatment with topical steroids. Literature reviews, studies of phimosis without LS and adult patients were excluded. Data analysed for each paper included age, duration of treatment, length of follow up and outcome, notably circumcision or no surgery.
Results
The original search identified 26 titles. Application of exclusion criteria left 6 articles for inclusion in the study. Eighty nine patients with LS were treated with topical corticosteroids. Circumcision was avoided in 31/89 (35%; range 0–100%). Median patient age was 6.5 years (1 month–15 years). Median duration of treatment was 2 months (1–23 months); median follow-up 4 months (6 weeks–5 years).
Conclusions
Treatment of LS with topical steroids reportedly avoided circumcision in 35% of boys. Duration of medical therapy and patient follow up in analysed studies were, however, short. A prospective randomised trial would provide a definitive answer.
Type of Study
Systematic review.
Level of Evidence
III.